Therapeutic potential and molecular mechanisms of Emblica officinalis gaertn in countering nephrotoxicity in rats induced by the chemotherapeutic agent cisplatin

Frontiers in Pharmacology

Volumn 7, Issue OCT, 2016, Pages

  Malik, Salma ^a   Suchal, Kapil ^a   Bhatia, Jagriti ^a   Khan, Sana I ^a   Vasisth, Swati ^a   Tomar, Ameesha ^a   Goyal, Sameer ^b   Kumar, Rajeev ^a   Arya, Dharamvir S ^a   Ojha, Shreesh K ^c  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b R C PATEL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH   (India)

^c UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Apoptosis; Cisplatin; Emblica officinalis; Inflammation; Nephrotoxicity; Oxidative stress

Indexed keywords

CATALASE; CISPLATIN; CREATININE; EMBLICA OFFICINALIS EXTRACT; GLUTATHIONE; INTERLEUKIN 6; MALONALDEHYDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NITROGEN; STRESS ACTIVATED PROTEIN KINASE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR; UREA;

ACUTE KIDNEY TUBULE NECROSIS; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG DOSE COMPARISON; FRUIT; MALE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PROTEIN PHOSPHORYLATION; RAT; RENAL PROTECTION; UREA NITROGEN BLOOD LEVEL;

EID: 84995495699     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2016.00350     Document Type: Article

References (63)

1. Aebi, H. (1984). Catalase in vitro. Methods Enzymol. 105, 121-126. doi: 10.1016/S0076-6879(84)05016-3
2. Al-Majed, A. A., Sayed-Ahmed, M. M., Al-Yahya, A. A., Aleisa, A. M., Al-Rejaie, S. S., and Al-Shabanah, O. A. (2006). Propionyl-L-carnitine prevents the progression of cisplatin-induced cardiomyopathy in a carnitine-depleted rat model. Pharmacol. Res. 53, 278-286. doi: 10.1016/j.phrs.2005.12.005
3. Athira, K. V., Madhana, R. M., and Lahkar, M. (2016). Flavonoids, the emerging dietary supplement against cisplatin-induced nephrotoxicity. Chem. Biol. Interact. 248, 18-20. doi: 10.1016/j.cbi.2016.02.005
4. Benedetti, G., Fredriksson, L., Herpers, B., Meerman, J., van de Water, B., and de Graauw, M. (2013). TNF-α-mediated NF-κB survival signaling impairment by cisplatin enhances JNK activation allowing synergistic apoptosis of renal proximal tubular cells. Biochem. Pharmacol. 85, 274-286. doi: 10.1016/j.bcp.2012.10.012
5. Bhatia, J., Tabassum, F., Sharma, A. K., Bharti, S., Golechha, M., Joshi, S., et al. (2011). Emblica officinalis exerts antihypertensive effect in a rat model of DOCA-salt-induced hypertension: role of (p) eNOS, NO and oxidative stress. Cardiovasc. Toxicol. 11, 272-279. doi: 10.1007/s12012-011-9122-2
6. Bolisetty, S., Traylor, A., Joseph, R., Zarjou, A., and Agarwal, A. (2016). Proximal tubule-targeted heme oxygenase-1 in cisplatin-induced acute kidney injury. Am. J. Physiol. Renal Physiol. 310, F385-F394. doi: 10.1152/ajprenal.00335.2015
7. Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254. doi: 10.1016/0003-2697(76)90527-3
8. Changizi-Ashtiyani, S., Alizadeh, M., Najafi, H., Babaei, S., Khazaei, M., Jafari, M., et al. (2016). Physalis alkekengi and Alhagi maurorum ameliorate the side effect of cisplatin-induced nephrotoxicity. Cancer Gene Ther. 23, 235-240. doi: 10.1038/cgt.2016.24
9. Cummings, B. S., and Schnellmann, R. G. (2002). Cisplatin-induced renal cell apoptosis: caspase 3-dependent and-independent pathways. J. Pharmacol. Exp. Ther. 302, 8-17. doi: 10.1124/jpet.302.1.8
10. Domitrovic, R., Cvijanovic, O., Pernjak-Pugel, E., Skoda, M., Mikelic, L., Crncevic-Orlic, Z., et al. (2013). Berberine exerts nephroprotective effect against cisplatin-induced kidney damage through inhibition of oxidative/nitrosative stress, inflammation, autophagy and apoptosis. Food Chem. Toxicol. 62, 397-406. doi: 10.1016/j.fct.2013.09.003
11. dos Santos, N. A., Carvalho Rodrigues, M. A., Martins, N. M., and dos Santos, A. C. (2012). Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update. Arch. Toxicol. 86, 1233-1250. doi: 10.1007/s00204-012-0821-7
12. Dutta, A. L., and Sahu, C. R. (2013). Emblica officinalis Garten fruits extract ameliorates reproductive injury and oxidative testicular toxicity induced by chlorpyrifos in male rats. Springerplus 2:541. doi: 10.1186/2193-1801-2-541
13. El-Naga, R. N. (2014). Pre-treatment with cardamonin protects against cisplatin-induced nephrotoxicity in rats: impact on NOX-1, inflammation and apoptosis. Toxicol Appl. Pharmacol. 274, 87-95. doi: 10.1016/j.taap.2013.10.031
14. El-Naga, R. N., and Mahran, Y. F. (2016). Indole-3-carbinol protects against cisplatin-induced acute nephrotoxicity: role of calcitonin gene-related peptide and insulin-like growth factor-1. Sci. Rep. 6:29857. doi: 10.1038/srep29857
15. Feeney, M. J. (2004). Fruits and the prevention of lifestyle-related diseases. Clin. Exp. Pharmacol. Physiol. 31, S11-S13. doi: 10.1111/j.1440-1681.2004.04104.x
16. Francescato, H. D., Costa, R. S., Júnior, F. B., and Coimbra, T. M. (2007). Effect of JNK inhibition on cisplatin-induced renal damage. Nephrol. Dial. Transplant. 22, 2138-2148. doi: 10.1093/ndt/gfm144
17. Golechha, M., Bhatia, J., and Arya, D. S. (2012). Studies on effects of Emblica officinalis (Amla) on oxidative stress and cholinergic function in scopolamine induced amnesia in mice. J. Environ. Biol. 33, 95-100.
18. Golechha, M., Sarangal, V., Ojha, S., Bhatia, J., and Arya, D. S. (2014). Anti-inflammatory effect of emblica officinalis in rodent models of acute and chronic inflammation: involvement of possible mechanisms. Int. J. Inflam. 2014:178408. doi: 10.1155/2014/178408
19. Guerrero-Beltrán, C. E., Mukhopadhyay, P., Horváth, B., Rajesh, M., Tapia, E., García-Torres, I., et al. (2012). Sulforaphane, a natural constituent of broccoli, prevents cell death and inflammation in nephropathy. J. Nutr. Biochem. 23, 494-500. doi: 10.1016/j.jnutbio.2011.02.004
20. Haque, R., Bin-Hafeez, B., Ahmad, I., Parvez, S., Pandey, S., and Raisuddin, S. (2001). Protective effects of Emblica officinalis Gaertn. in cyclophosphamide-treated mice. Hum. Exp. Toxicol. 20, 643-650. doi: 10.1191/096032701718890568
21. Jaiman, S., Sharma, A. K., Singh, K., and Khanna, D. (2013). Signalling mechanisms involved in renal pathological changes during cisplatin-induced nephropathy. Eur. J. Clin. Pharmacol. 69, 1863-1874. doi: 10.1007/s00228-013-1568-7
22. Jiang, M., Wang, C. Y., Huang, S., Yang, T., and Dong, Z. (2009). Cisplatin-induced apoptosis in p53-deficient renal cells via the intrinsic mitochondrial pathway. Am. J. Physiol. Renal Physiol. 296, F983-F993. doi: 10.1152/ajprenal.90579.2008
23. Kim, H. J., Ravichandran, K., Ozkok, A., Wang, Q., He, Z., Jani, A., et al. (2014). The water-soluble triptolide derivative PG490-88 protects against cisplatin-induced acute kidney injury. J. Pharmacol. Exp. Ther. 349, 518-525. doi: 10.1124/jpet.114.213769
24. Kim, H. J., Yokozawa, T., Kim, H. Y., Tohda, C., Rao, T. P., and Juneja, L. R. (2005). Influence of amla (Emblica officinalis Gaertn.) on hypercholesterolemia and lipid peroxidation in cholesterol-fed rats. J. Nutr. Sci. Vitaminol. 51, 413-418. doi: 10.3177/jnsv.51.413
25. Kim, H. Y., Okubo, T., Juneja, L. R., and Yokozawa, T. (2010). The protective role of amla (Emblica officinalis Gaertn.) against fructose-induced metabolic syndrome in a rat model. Br. J. Nutr. 103, 502-512. doi: 10.1017/S0007114509991978
26. Krishnaveni, M., and Mirunalini, S. (2010). Therapeutic potential of Phyllanthus emblica (amla): the ayurvedic wonder. J. Basic Clin. Physiol. Pharmacol. 21, 93-105.
27. Liu, X., Huang, Z., Zou, X., Yang, Y., Qiu, Y., and Wen, Y. (2014). Panax notoginseng saponins attenuates cisplatin-induced nephrotoxicity via inhibiting the mitochondrial pathway of apoptosis. Int. J. Clin. Exp. Pathol. 7, 8391-8400.
28. Ma, X., Dang, C., Kang, H., Dai, Z., Lin, S., Guan, H., et al. (2015). Saikosaponin-D reduces cisplatin-induced nephrotoxicity by repressing ROS-mediated activation of MAPK and NF-κB signalling pathways. Int. Immunopharmacol. 28, 399-408. doi: 10.1016/j.intimp.2015.06.020
29. Mahata, S., Pandey, A., Shukla, S., Tyagi, A., Husain, S. A., Das, B. C., et al. (2013). Anticancer activity of Phyllanthus emblica Linn. (Indian gooseberry): inhibition of transcription factor AP-1 and HPV gene expression in cervical cancer cells. Nutr. Cancer 65(Suppl. 1), 88-97. doi: 10.1080/01635581.2013.785008
30. Malik, S., Suchal, K., Gamad, N., Dinda, A. K., Arya, D. S., and Bhatia, J. (2015). Telmisartan ameliorates cisplatin-induced nephrotoxicity by inhibiting MAPK mediated inflammation and apoptosis. Eur. J. Pharmacol. 748, 54-60. doi: 10.1016/j.ejphar.2014.12.008
31. Marklund, S., and Marklund, G. (1974). Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 47, 469-474. doi: 10.1111/j.1432-1033.1974.tb03714.x
32. Miller, R. P., Tadagavadi, R. K., Ramesh, G., and Reeves, W. B. (2010). Mechanisms of Cisplatin nephrotoxicity. Toxins (Basel). 2, 2490-2518. doi: 10.3390/toxins2112490
33. Moron, M. S., Depierre, J. W., and Mannervik, B. (1979). Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim. Biophys. Acta 582, 67-78. doi: 10.1016/0304-4165(79)90289-7
34. Muthuraman, A., Sood, S., and Singla, A. K. (2011). The antiinflammatory potential of phenolic compounds from Emblica officinalis L. in rat. Inflammopharmacology 19, 327-334. doi: 10.1007/s10787-010-0041-9
35. Nain, P., Saini, V., Sharma, S., and Nain, J. (2012). Antidiabetic and antioxidant potential of Emblica officinalis Gaertn. leaves extract in streptozotocin-induced type-2 diabetes mellitus (T2DM) rats. J. Ethnopharmacol. 142, 65-71. doi: 10.1016/j.jep.2012.04.014
36. Nojiri, T., Hosoda, H., Kimura, T., Miura, K., Ishikane, S., Tokudome, T., et al. (2015). Atrial natriuretic peptide protects against cisplatin-induced acute kidney injury. Cancer Chemother. Pharmacol. 75, 123-129. doi: 10.1007/s00280-014-2624-4
37. Oh, G. S., Kim, H. J., Shen, A., Lee, S. B., Khadka, D., Pandit, A., et al. (2014). Cisplatin-induced kidney dysfunction and perspectives on improving treatment strategies. Electrolyte Blood Press. 12, 55-65. doi: 10.5049/EBP.2014.12.2.55
38. Oh, G. S., Kim, H. J., Shen, A., Lee, S. B., Yang, S. H., Shim, H., et al. (2016). New therapeutic concept of NAD redox balance for cisplatin nephrotoxicity. Biomed. Res. Int. 2016:4048390. doi: 10.1155/2016/4048390
39. Ohkawa, H., Ohishi, N., and Yagi, K. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95, 351-358. doi: 10.1016/0003-2697(79)90738-3
40. Pabla, N., and Dong, Z. (2008). Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int. 73, 994-1007. doi: 10.1038/sj.ki.5002786
41. Pabla, N., Murphy, R. F., Liu, K., and Dong, Z. (2009). The copper transporter Ctr1 contributes to cisplatin uptake by renal tubular cells during cisplatin nephrotoxicity. Am. J. Physiol. Renal Physiol. 296, 505-511. doi: 10.1152/ajprenal.90545.2008
42. Pan, H., Chen, J., Shen, K., Wang, X., Wang, P., Fu, G., et al. (2015). Mitochondrial modulation by Epigallocatechin 3-Gallate ameliorates cisplatin induced renal injury through decreasing oxidative/nitrative stress, inflammation and NF-kB in mice. PLoS ONE 10:e0124775. doi: 10.1371/journal.pone.0124775
43. Quesada, A., Vargas, F., Montoro-Molina, S., O'Valle, F., Rodríguez-Martínez, M. D., Osuna, A., et al. (2012). Urinary aminopeptidase activities as early and predictive biomarkers of renal dysfunction in cisplatin-treated rats. PLoS ONE 7:e40402. doi: 10.1371/journal.pone.0040402
44. Ramesh, G., and Reeves, W. B. (2005). p38MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice. Am. J. Physiol. Renal. Physiol. 289, F166-F174. doi: 10.1152/ajprenal.00401.2004
45. Ramesh, G., and Reeves, W. B. (2006). Cisplatin increases TNF-alpha mRNA stability in kidney proximal tubule cells. Ren. Fail. 28, 583-592. doi: 10.1080/08860220600843839
46. Reddy, V. D., Padmavathi, P., Hymavathi, R., Maturu, P., and Varadacharyulu, N. Ch (2014). Alcohol-induced oxidative stress in rat liver microsomes: Protective effect of Emblica officinalis. Pathophysiology 21, 153-159. doi: 10.1016/j.pathophys.2013.12.001
47. Sahu, B. D., Kalvala, A. K., Koneru, M., Mahesh, Kumar J, Kuncha, M., Rachamalla, S. S., et al. (2014). Ameliorative effect of fisetin on cisplatin-induced nephrotoxicity in rats via modulation of NF-kappaB activation and antioxidant defence. PLoS ONE 9:e105070. doi: 10.1371/journal.pone.0105070
48. Seth, R., Yang, C., Kaushal, V., Shah, S. V., and Kaushal, G. P. (2005). p53-dependent caspase-2 activation in mitochondrial release of apoptosis-inducing factor and its role in renal tubular epithelial cell injury. J. Biol. Chem. 280, 31230-31239. doi: 10.1074/jbc. M503305200
49. Singh, M. K., Yadav, S. S., Gupta, V., and Khattri, S. (2013). Immunomodulatory role of Emblica officinalis in arsenic induced oxidative damage and apoptosis in thymocytes of mice. BMC Complement. Altern. Med. 13:193. doi: 10.1186/1472-6882-13-193
50. Singh, M. K., Yadav, S. S., Yadav, R. S., Singh, U. S., Shukla, Y., Pant, K. K., et al. (2014). Efficacy of crude extract of Emblica officinalis (amla) in arsenic-induced oxidative damage and apoptosis in splenocytes of mice. Toxicol. Int. 21, 8-17. doi: 10.4103/0971-6580.128784
51. Song, K. I., Park, J. Y., Lee, S., Lee, D., Jang, H. J., Kim, S. N., et al. (2015). Protective effect of tetrahydrocurcumin against cisplatin-induced renal damage: in vitro and in vivo studies. Planta Med. 81, 286-291. doi: 10.1055/s-0035-1545696
52. Sumitra, M., Manikandan, P., Gayathri, V. S., Mahendran, P., and Suguna, L. (2009). Emblica officinalis exerts wound healing action through up-regulation of collagen and extracellular signal-regulated kinases (ERK1/2). Wound Repair Regen. 17, 99-107. doi: 10.1111/j.1524-475X.2008.00446.x
53. Tayem, Y., Johnson, T. R., Mann, B. E., Green, C. J., and Motterlini, R. (2006). Protection against cisplatin-induced nephrotoxicity by a carbon monoxide-releasing molecule. Am. J. Physiol. Renal Physiol. 290, F789-F794. doi: 10.1152/ajprenal.00363.2005
54. Tsuruya, K., Ninomiya, T., Tokumoto, M., Hirakawa, M., Masutani, K., Taniguchi, M., et al. (2003). Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death. Kidney Int. 63, 72-82. doi: 10.1046/j.1523-1755.2003.00709.x
55. Verma, R., and Chakraborty, D. (2008). Alterations in DNA, RNA and protein contents in liver and kidney of mice treated with ochratoxin and their amelioration by Emblica officinalis aqueous extract. Acta Pol. Pharm. 65, 3-9.
56. Wang, Y., Luo, X., Pan, H., Huang, W., Wang, X., Wen, H., et al. (2015). Pharmacological inhibition of NADPH oxidase protects against cisplatin induced nephrotoxicity in mice by two step mechanism. Food Chem. Toxicol. 83, 251-260. doi: 10.1016/j.fct.2015.05.007
57. Wei, Q., Dong, G., Franklin, J., and Dong, Z. (2007). The pathological role of Bax in cisplatin nephrotoxicity. Kidney Int. 72, 53-62. doi: 10.1038/sj.ki.5002256
58. Xu, Y., Ma, H., Shao, J., Wu, J., Zhou, L., Zhang, Z., et al. (2015). A role for tubular necroptosis in cisplatin-induced AKI. J. Am. Soc. Nephrol. 26, 2647-2658. doi: 10.1681/ASN.2014080741
59. Yousef, M. I., and Hussien, H. M. (2015). Cisplatin-induced renal toxicity via tumor necrosis factor-a, interleukin 6, tumor suppressor P53, DNA damage, xanthine oxidase, histological changes, oxidative stress and nitric oxide in rats: protective effect of ginseng. Food Chem. Toxicol. 78, 17-25. doi: 10.1016/j.fct.2015.01.014
60. Yüce, A., Atessahin, A., Ceribasi, A. O., and Aksakal, M. (2007). Ellagic acid prevents cisplatin-induced oxidative stress in liver and heart tissue of rats. Basic Clin. Pharmacol. Toxicol. 101, 345-349. doi: 10.1111/j.1742-7843.2007.00129.x
61. Zhang, B., Ramesh, G., Norbury, C. C., and Reeves, W. B. (2007). Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-alpha produced by renal parenchymal cells. Kidney Int. 72, 37-44. doi: 10.1038/sj.ki.5002242
62. Zhou, Y., Xu, H., Xu, W., Wang, B., Wu, H., Tao, Y., et al. (2013). Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro. Stem Cell Res. Ther. 4:34. doi: 10.1186/scrt194
63. Zirak, M. R., Rahimian, R., Ghazi-Khansari, M., Abbasi, A., Razmi, A., Mehr, S. E., et al. (2014). Tropisetron attenuates cisplatin-induced nephrotoxicity in mice. Eur. J. Pharmacol. 738, 222-229. doi: 10.1016/j.ejphar.2014.05.050